169 related articles for article (PubMed ID: 37489043)
21. Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors.
Yang S; Wang C; Shi L; Chang J; Zhang Y; Meng J; Liu W; Zeng J; Zhang R; Shao Y; Xing D
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2755-2764. PubMed ID: 36196773
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Novel Diarylamide
Liu X; Pang XJ; Liu Y; Liu WB; Li YR; Yu GX; Zhang YB; Song J; Zhang SY
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279387
[TBL] [Abstract][Full Text] [Related]
23. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and bioevaluation of novel stilbene-based derivatives as tubulin/HDAC dual-target inhibitors with potent antitumor activities in vitro and in vivo.
Zhu H; Zhu W; Liu Y; Gao T; Zhu J; Tan Y; Hu H; Liang W; Zhao L; Chen J; Zhu Z; Chen J; Xu J; Xu S
Eur J Med Chem; 2023 Sep; 257():115529. PubMed ID: 37269670
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors.
Yang W; Peng H; Huang Y; Peng Z; Wang G
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2530-2539. PubMed ID: 36100238
[TBL] [Abstract][Full Text] [Related]
28. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells.
Wang S; Malebari AM; Greene TF; Kandwal S; Fayne D; Nathwani SM; Zisterer DM; Twamley B; O'Boyle NM; Meegan MJ
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513912
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of antiproliferative microtubule-destabilising combretastatin A-4 piperazine conjugates.
O'Boyle NM; Ana G; Kelly PM; Nathwani SM; Noorani S; Fayne D; Bright SA; Twamley B; Zisterer DM; Meegan MJ
Org Biomol Chem; 2019 Jun; 17(25):6184-6200. PubMed ID: 31173031
[TBL] [Abstract][Full Text] [Related]
34. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
[TBL] [Abstract][Full Text] [Related]
36. Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells.
Fu DJ; Liu SM; Yang JJ; Li J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1403-1413. PubMed ID: 32588683
[TBL] [Abstract][Full Text] [Related]
37. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
[TBL] [Abstract][Full Text] [Related]
39. Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors.
Li X; Wu H; Feng KW; Xu J; Wu S; Zhou ZZ; Li XF
Bioorg Med Chem; 2022 Nov; 73():117007. PubMed ID: 36150341
[TBL] [Abstract][Full Text] [Related]
40. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
Li YR; Liu FF; Liu WB; Zhang YF; Tian XY; Fu XJ; Xu Y; Song J; Zhang SY
Biochem Pharmacol; 2022 Jul; 201():115070. PubMed ID: 35526597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
